Keiji Matsui Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2003

Circulating endothelial progenitor cells are reduced in hemodialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keiji Matsui Research Topics

Disease

2	COVID-19 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 05/2017 - 01/2014
1	Telangiectasis (Telangiectasia) 07/2020
1	Polycythemia (Erythrocytosis) 07/2020
1	Ascites 07/2020
1	Paraproteinemias (Monoclonal Gammopathy) 07/2020
1	Hepatocellular Carcinoma (Hepatoma) 05/2017
1	Hepatitis B 05/2017
1	Diabetes Mellitus 05/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2014
1	Breast Neoplasms (Breast Cancer) 04/2012
1	Sinusitis 01/2011
1	Ulcerative Colitis 01/2011
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2011
1	Liver Diseases (Liver Disease) 01/2011
1	Hepatitis C 08/2010
1	Persistent Infection 08/2010
1	Aortic Aneurysm (Aneurysm, Aortic) 05/2004
1	Peripheral Arterial Disease 08/2003
1	Arteriosclerosis Obliterans 08/2003
1	Thromboangiitis Obliterans (Buerger's Disease) 08/2003
1	Myocardial Infarction 05/2003
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2003
1	Atherosclerosis 04/2002
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2002

Drug/Important Bio-Agent (IBA)

3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2004 - 05/2003
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2003 - 04/2002
2	InterferonsIBA 01/2014 - 08/2010
1	Neutralizing AntibodiesIBA 01/2022
1	AntibodiesIBA 01/2021
1	Erythropoietin FDA Link 07/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2017
1	Antiviral Agents (Antivirals)IBA 05/2017
1	nuclear pore complex protein 98IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 04/2012
1	Estrogen ReceptorsIBA 04/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2011
1	montelukast (Singulair)FDA Link 01/2011
1	Interferon-betaIBA 08/2010
1	Ribavirin (Virazole)FDA LinkGeneric 08/2010
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 08/2003
1	Troleandomycin (TAO)FDA Link 08/2003
1	Macrophage Colony-Stimulating FactorIBA 08/2003
1	Angiotensin IIIBA 05/2003
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2003
1	Angiotensin II Type 1 Receptor BlockersIBA 05/2003
1	Alprostadil (Muse)FDA LinkGeneric 02/2003

Therapy/Procedure

3	Therapeutics 01/2014 - 08/2010
1	Peritoneovenous Shunt 07/2020
1	Blood Vessel Prosthesis 05/2004
1	Renal Dialysis (Hemodialysis) 01/2003